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The primary pathogens related to shellfishborne gas-
troenteritis outbreaks are noroviruses. These viruses show
persistence in oysters, which suggests an active mecha-
nism of virus concentration. We investigated whether
Norwalk virus or viruslike particles bind specifically to oys-
ter tissues after bioaccumulation or addition to tissue sec-
tions. Since noroviruses attach to carbohydrates of the
histo-blood group family, tests using immunohistochemical
analysis were performed to evaluate specific binding of
virus or viruslike particles to oyster tissues through these
ligands. Viral particles bind specifically to digestive ducts
(midgut, main and secondary ducts, and tubules) by carbo-
hydrate structures with a terminal N-acetylgalactosamine
residue in an α linkage (same binding site used for recog-
nition of human histo-blood group antigens). These data
show that the oyster can selectively concentrate a human
pathogen and that conventional depuration will not elimi-
nate noroviruses from oyster tissue.
T
welve years ago, the question, “Should shellfish be
purified before public consumption?” was asked in
Lancet (1). Since then, new evidence of gastroenteritis out-
breaks linked to shellfish consumption, even depurated
shellfish, has been published, and raw or cooked oysters
are the predominant bivalve mollusks involved (2–5).
Regulations for Escherichia coli counts in shellfish-grow-
ing waters (United States) or shellfish meat (European
Community) have failed to protect consumers because
most shellfish-associated gastroenteritis outbreaks have a
viral origin (4). Enteric viruses are different from enteric
bacteria in terms of resistance to sewage treatment, persist-
ence under unfavorable conditions such as occur in sea
water, and transmission into the environment (6–8).
Shellfish mollusks cultivated in coastal areas close to
human activities can be contaminated by human sewage,
which can spread >100 types of viruses (9). Viruses persist
in shellfish for an extended period and can adversely affect
public health; despite improvements, depuration does not
eliminate viral particles (2,10–14).
Noroviruses are the most frequent cause of diarrhea
outbreaks in all age groups (8,15). These viruses, which
are commonly associated with foodborne and waterborne
outbreaks, are resistant to sewage treatment and are pres-
ent in high concentrations during the epidemic season
(3,7,15). They are the primary pathogens associated with
shellfishborne outbreaks worldwide (3,4).Oysters are rap-
idly contaminated, as shown by outbreaks linked to acci-
dental input, and viruses then persist for up to several
weeks (2,13,16). These data suggest that contamination by
a passive process during mollusk filter feeding may be too
simplistic an explanation. We tested whether oysters can
actively capture noroviruses and determined the fate of
prototype genogroup I Norwalk virus particles in bioaccu-
mulation experiments. Since noroviruses can attach to car-
bohydrates of the ABH and Lewis histo-blood group
family in humans, we also examined the possibility of a
similar specific binding to oyster tissues through related
carbohydrates (17,18).
Materials and Methods
Norwalk Virus Strain and Recombinant 
Viruslike Particles
Norwalk virus strain 8FIIa was purified from a stool
sample of an infected volunteer and assayed by reverse
transcription–polymerase chain reaction (RT-PCR) end-
point dilution (RT-PCR units) to determine the amount of
viral RNAin the sample (19). Based on the equivalence of
1 RT-PCR unit to 30–40 genomic copies of RNA, the titer
was estimated to be ≈3 × 1010 particles/mL (2).
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were used to produce recombinant viruslike particles
(VLPs) as described previously (20). Virus concentration,
as calculated with the detergent compatible protein assay
(Bio-Rad Laboratories, Hercules, CA, USA), was 2.11 ×
1015 particles/mL. The number of particles in 1 µg of VLPs
was calculated by multiplying the molecular mass of the
major capsid protein VP1 (58 kDa) by the number of
copies of the protein in a particle (180) and by a mass of
1 Da (1.66 × 10–24 g) (21).
Mutants in the P2 subdomain of VP1 were generated by
Ala point substitution and used to produce recombinant
VLPs His 329 (H329A), Asn 331 (N331A), and Trp 375
(W375A) (22). Concentrations of these 3 mutant VLPs
were adjusted to 5.78 × 1014 particles/mL.
Oysters
All experiments were performed with Crassostrea
gigas from a clean area (Class A, European Regulations),
with no viral contamination, as tested after viral concentra-
tion, RNA extraction, and RT-PCR (2). Two batches of
oysters collected in March and October 2004 were used to
prepare tissue sections.
Bioaccumulation of Norwalk Virus 
and Recombinant VLPs
Norwalk virus (5 × 108 particles) orrecombinant VLPs
(1012 or 109 particles) were added to 500 mL clean sea
water and homogenized for 5 min. Three oysters were
added to the sea water and incubated at room temperature
for 12 or 24 h. Sea water was continuously aerated to
maintain adequate oxygen levels. A negative control was
used under similar conditions but without the addition of
Norwalk virus or recombinant VLPs. 
Immunohistochemical Analysis
Oysters (uncontaminated or after bioaccumulation)
were shucked, and the flesh was fixed in 10% formalde-
hyde for 48 hours. The digestive gland was then dissected,
embedded in paraffin, and sliced into thin sections (5 µm).
After preparation of tissue sections, sections from uncont-
aminated oysters were covered with 4 × 109 particles of
recombinant wild-type VLPs, 3 × 109 particles of Norwalk
virus, or 2 × 108 particles of mutant VLPs, incubated
overnight at 4°C, and washed 3 times (5 min per wash) in
phosphate-buffered saline (PBS) at room temperature (23).
VLPs bound to oyster tissue or virus trapped after the
bioaccumulation experiments was detected by using a rab-
bit polyclonal antibody to recombinant VLP as previously
described (23). Negative controls included sections from
uncontaminated samples not exposed to Norwalk virus or
recombinant VLPs and virus-exposed sections without
antibody. Immunoreactivity, which was detected by micro-
scopic analysis, was graded as strong (intense brown-red
staining), weak (pale brown-red staining), or negative (no
staining). 
Inhibition of Recombinant VLP Binding 
to Tissue Sections
Treatment with periodate was performed as previously
described (23). VLPs were incubated overnight on slides,
and the immunohistochemical detection was conducted.
Saliva samples from 18 persons with secretor type O, 14
with secretor type A, 4 with secretor type B, and 5 nonse-
cretors were tested. Phenotyping was performed by
enzyme-linked immunosorbent assay, and secretor pheno-
type was confirmed by genotyping as previously described
(17).For the inhibition assay, VLPs were mixed with sali-
va samples diluted 1:100 for 90 min at room temperature,
placed on shellfish tissues, and incubated overnight at 4°C.
Positive (without treatment) and negative (without recom-
binant VLPs) samples were included in this assay.
Binding and Inhibition by Specific Lectins 
and Carbohydrate-specific Antibodies
Three biotinylated lectins, derived from Helix pomatia
(HPA),  Dolichos biflorus (DBA), and Ulex europaeus
(UEA-1) (Biovalley SA, Marne la Vallée, France), were
used for analysis of binding to tissues and inhibition of
VLPbinding. UEA-1 recognizes the H type 2 trisaccharide
and shows some cross-reactivity with Ley. HPA and DBA
recognize  α-linked N-acetylgalactosamine residues. For
the binding assay, lectins were applied to shellfish tissues
for 30 min at different concentrations (50, 20, 10, 5, and
1 µg/mL). 
Monoclonal antibodies were used for tissue staining.
The antibodies used were anti-A (3-3A), which recognizes
all Aepitopes; anti-Atypes 3/4 (III-2A3, III-2A18, and III-
2A24); anti-Atype 2 (III-2A5); anti-H/Leb (LM-137); anti-
H type 2 (19-OLE); anti-Ley (12-4LE); and anti-H type 1.
The primary antibodies were serially diluted, incubated
with tissues overnight at 4°C, and subjected to standard
immunohistochemical analysis (23). Negative (without
lectin or primary antibody) and positive (known rat or
human tissue sections) controls were also tested. For inhi-
bition assays, antibodies or lectins were applied to shell-
fish tissues for 1 h at 37°C or 1 h at 4°C, respectively, at
concentrations 10-fold higher than the lowest dilution that
showed binding to the oyster tissues, incubated with VLPs,
and analyzed as described above.
Results
Binding of Virus in Oysters after Bioaccumulation
Oysters were immersed in sea water seeded with
Norwalk virus at a final concentration of 106 particles/mL
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2 × 106 particles/mL. After incubation for 12 h, virus was
detected in digestive diverticula. Immunostaining showed
particles in the lumen of tubules and ducts or in phagocytes
between epithelial cells and in the surrounding connective
tissue (Figure, panels A and B). No difference was
observed for the 2 recombinant VLP concentrations used.
After incubation for 24 h in sea water at final concentra-
tions of 5 × 108 and 5 ×109 particles/mL for Norwalk virus
and recombinant VLPs, respectively, similar results were
obtained with particles binding to digestive ducts and iso-
lated cells in connective tissue (data not shown).
Binding of Virus in Oyster Digestive Tissues
The binding of virus or recombinant VLPs was tested
directly on oyster gut sections. Both recombinant VLPs
and native virions bound to the midgut, the main and sec-
ondary ducts of the digestive diverticula, and tubules,
although labeling of tubules was weaker (Figure, panels C,
D, and E). Binding to connective tissue was not observed.
Staining was not observed in negative controls. 
Recombinant VLPs can attach to human digestive
epithelial cells by recognizing carbohydrate structures. To
determine if attachment to oyster digestive cells was also
carbohydrate dependent, tissues sections were treated with
10 mmol/L sodium periodate before adding the VLPs. A
reduction in VLP binding occurred, which suggested that,
similar to the case with human tissue, binding to oyster tis-
sue involves carbohydrates (Figure, panels E and F).
Inhibition of Virus Binding to Oyster Digestive 
Cells by Human Saliva
Since attachment of recombinant VLPs to human tissue
sections involves carbohydrates of the ABH, secretor, and
Lewis histo-blood group family, which are present on
human salivary mucins, we evaluated the ability of saliva
of different ABO and secretor phenotypes to block the
binding of VLPs to shellfish tissues. Complete inhibition
of binding was observed after pretreatment of the recombi-
nant VLPs with type A secretor saliva, and binding was
markedly reduced after incubation with type O secretor
saliva. However, after incubation with type B secretor sali-
va or nonsecretor saliva, binding was as strong as that
observed in positive controls (Table 1). All samples in sub-
groups of saliva showed similar patterns.
Binding of Mutant Recombinant VLPs
Our results suggested that attachment of VLPs to oys-
ter tissue involves carbohydrate binding sites that overlap
the site that attaches to human digestive cells. This site has
been mapped to a restricted area of the viral capsid P2
domain. Mutations in key residues in this domain inacti-
vate the binding activity to histo-blood group structures.
To confirm that the binding to oyster tissue involved the
same binding site, VLPs with point mutations were tested.
Among 3 mutants, only mutant N331A binds to tissues
similar to parental recombinant VLP (Figure, panel G).
The 2 other mutants, H329A and W375A, did not bind to
tissues (Figure, panel H). 
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Figure. Immunohistochemical detection of Norwalk viruslike particles (VLPs) in oyster digestive tissue. A) VLPs in the digestive divertic-
ulum 12 h after seeding sea water with 109 particles. The arrows show immunoreactivity detected in intraepithelial cells. B) VLPs in the
digestive diverticulum 12 h after seeding sea water with 1012 particles. The arrowhead shows immunoreactivity in a phagocyte located
in connective tissue, and the arrow shows immunoreactivity in the lumen of a digestive tubule. C) Attachment of recombinant VLPs to
secondary ducts of the digestive diverticula after incubation on tissue sections. The arrows show immunoreactivity in the lumen of ducts.
D) Attachment of Norwalk virus to a main digestive duct. The arrow shows immunoreactivity in epithelial duct cells. E and F) Attachment
(arrows) of recombinant VLPs to digestive ducts without (E) or with (F) periodate treatment of serial tissue sections. G) Binding of VLPs
(arrows) to a main digestive duct of VLPs from the H331A mutant capsid protein. H) Lack of binding of the H329A mutant. I) Binding of
HPA lectin to the digestive diverticula. Scale bars: A and B, 10 µm; C, E, F, and H, 40 µm; D, G, and I, 20 µm.Inhibition of VLP Binding by Antibodies to
Carbohydrate and Lectins
Antibodies to carbohydrates on cells in the human
digestive tract can inhibit binding of recombinant VLPs to
human tissue (18). Primary antibodies that recognize vari-
ous determinants of the histo-blood group family were
evaluated for binding to oyster digestive tract and inhibi-
tion of VLP binding. Antibodies that recognize all types of
Adeterminants (3-3A) or those that are restricted to Atype
3/4 determinants bound strongly to shellfish tissues
(Table 2). Anti-H type 1 BG-4 labeled oyster digestive
cells intracellularly and also labeled connective tissue.
Antibody LM137, which recognizes all H determinants
and Leb tetrasaccharide, also labeled connective tissue and
digestive epithelial cells intracellularly. However, staining
had a more punctiform appearance. Despite recognition of
oyster ligands, in inhibition assays none of these antibod-
ies inhibited binding of VLPs to oyster tissues. Antibodies
directed against H type 2 (19-OLE,), Ley (12-4LE), or A
type 2 epitopes (III-2A-5) showed little staining of shell-
fish tissues and when positive, staining did not correspond
to cells to which VLPs bind. These results indicate that
oyster tissues have carbohydrates that resemble human
histo-blood group antigens, but structures recognized by
VLPs were not identical to those recognized by these anti-
bodies. 
Lectins have been used to determine the distribution of
carbohydrate residues in tissue. Since lectins have a broad-
er reactivity than monoclonal antibodies, we used lectins
to identify recombinant VLP-specific carbohydrate ligand
in oyster tissue. UEA-1 bound to shellfish tissues, but only
at high concentration (50 µg/mL), whereas 2 other lectins,
DBA and HPA, bound at a lower concentration (1 µg/mL)
(Table 3). Tissue and cellular distribution of staining over-
lapped with that of the recombinant VLPs (Figure, panel
I). When these lectins were used in an inhibition assay,
only HPA had an inhibitory effect on binding of recombi-
nant VLPs to shellfish tissues. Complete inhibition was
observed at a concentration of 25 µg/mL (Table 3). This
inhibitory effect was reproducible and observed on tissues
from different shellfish, indicating that attachment of
recombinant VLPs to oysters involves carbohydrate
structures with a terminal N-acetylgalactosamine residue
in an α linkage. 
Discussion
Virus-mediated disease can be transmitted when con-
taminated shellfish are eaten. Oysters are believed to act as
filters or ionic traps, passively concentrating particles. A
simple depuration process should be sufficient to rid oys-
ters of virus, as observed for bacteria (12). However, long-
term virus persistence in shellfish is a serious public health
issue, and depuration or relaying is known to be inefficient
(10,12,14). After bioaccumulation, only 7% of Norwalk
virus is depurated, compared to a 95% reduction in bacte-
rial levels (13). Virus is located mainly in pancreatic tissue
(digestive diverticula), and various mechanisms have been
suggested to explain differences between oyster species
regarding virus accumulation, such as mechanical entrap-
ment or ionic bonding (10,13,24,25).
Our data demonstrate specific binding of viral particles
from a genogroup I norovirus to the oyster digestive tract
and suggest a specific mechanism for concentration of
virus particles. We tested recombinant VLPs of prototype
genogroup I Norwalk virus. VLPs are stable in the marine
environment and the disinfection processes (14,26).
Bioaccumulation and tissue-binding experiments showed
no difference between native Norwalk virus and VLPs,
which confirmed that VLPs are good surrogates of infec-
tious virions. 
Different results were seen between bioaccumulation
experiments and particle binding to tissues sections. After
bioaccumulation, some viral particles were detected in
phagocytes in either epithelium or connective tissue. This
finding could reflect elimination of virus during digestion.
The time required for food to pass through the entire shell-
fish intestinal tract varies from 90 to 150 min. We do not
know whether immunoreactive material detected in phago-
cytes corresponds to particle degradation and digestion or
if particles can escape digestion. Binding to main ducts
may provide a mechanism for viral particles to avoid enter-
ing the digestive system and being degraded. Specific
attachment of virus to oyster cells and capture by
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an effective mechanism for eliminating virus.
Virus accumulation in oysters may depend on factors
such as water temperature, mucus production, glycogen
content of connective tissue, or gonadal development (25).
In our study, no difference was seen in binding location
between samples collected in March or October, although
studies during other seasons are warranted.
Human susceptibility factors for norovirus infections
that depend upon carbohydrates of the ABH, secretor, and
Lewis histo-blood group family have been observed
(17,27). We showed that recognition of oyster digestive
epithelial cells by recombinant VLPs also involves carbo-
hydrates. The ability of human saliva to inhibit attachment
of VLPs to oyster tissue in a histo-blood group–dependent
manner indicates involvement of the histo-blood group
binding site and the viral P2 subdomain (18).
Similar to human histo-blood group structures, mutant
VLPs showed that an alanine substitution at positions
H329A and W375A prevented binding to oyster tissue.
However, a mutant with a substitution at position N331A
did not affect binding. This binding specificity identified
the amino acids required for binding and further confirmed
the similarity with the mechanism of recognition of human
tissues (22). However, inhibition experiments using anti-
bodies to carbohydrates showed that ligands on oyster tis-
sues are not identical to those on human tissues. Since
attachment of recombinant VLPs was blocked by lectin
from  H.  pomatia, which recognizes α-linked N-acetyl-
galactosamine terminal residues of glycans, the oyster lig-
ands are similar to those of histo-blood group A. The DBA
lectin did not inhibit attachment of recombinant VLPs,
which indicates that it does not bind oligosaccharide struc-
tures recognized by VLPs and HPA. Although DBA binds
to N-acetylgalactosamine residues similar to HPA, the 2
lectins have different carbohydrate specificities that depend
on the subjacent sugar residues (28). Thus, Norwalk virus
binds to oyster tissues through an A-like carbohydrate
structure recognized by HPA at a binding site also used for
attachment to carbohydrate on human epithelial cells. 
Genogroup I and II strains of norovirus show various
binding patterns with different carbohydrate structures of
the histo-blood group family, which suggests coevolution
of this group of viruses and their host or carrier vector. The
ability of Norwalk virus to bind to oysters tissues at the
same binding site as that used to bind to human tissues
suggests a possible coevolution mechanism involving the
oyster as an intermediary vector. This mechanism would
favor selection of some viruses, such as Norwalk virus,
over other viruses that are unable to bind to the oyster and
would not be transmittable by this intermediary host.
Epidemiologic data suggest a predominance of genogroup
I strains in oyster-related gastroenteritis outbreaks, where-
as genogroup II strains are predominant in other food-
related outbreaks (2,3,5,8,15,16). To clearly address this
point, binding of other norovirus strains needs to be evalu-
ated because VLP-carbohydrate binding patterns differ,
and binding should also be evaluated with other shellfish
species (18,27).
As knowledge increases in understanding the binding
of these viruses in humans, we will likely further under-
stand more about their behavior in shellfish. This knowl-
edge may help identify species that could be less sensitive
to contamination. Since the oyster can actively and specif-
ically bind a human pathogen, this knowledge has practi-
cal consequences because conventional depuration cannot
eliminate noroviruses from oyster tissues.
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